Dirk Hondmann,Eric A.F. van Tol,Gabriele Gross,Marieke H. Schoemaker,Teartse Tim Lambers
申请号：
US13839212
公开号：
US20140274892A1
申请日:
2013.03.15
申请国别(地区):
US
年份:
2014
代理人:
摘要：
The present disclosure provides a method for reducing the risk of autoimmune disease by administering a composition comprising peptides selected from a casein hydrolysate. Such a composition, may reduce the symptoms of autoimmune disease and may be a treatment for autoimmune disease, especially type 1 diabetes. Preferably, the hydrolysate consists of peptides with a molecular weight of more than 500 Da.
